CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q2 2023$40,878
-82.8%
13,857
-85.4%
0.00%
Q1 2023$237,743
-15.5%
95,097
+7.1%
0.00%
Q4 2022$281,502
+6.6%
88,8020.0%0.00%
Q3 2022$264,000
-2.6%
88,8020.0%0.00%
Q2 2022$271,000
-76.5%
88,802
+4.0%
0.00%
Q1 2022$1,153,000
+4.6%
85,397
+1.0%
0.00%
Q4 2021$1,102,000
+43.7%
84,550
+3.4%
0.00%
Q3 2021$767,000
-50.7%
81,765
-46.2%
0.00%
-100.0%
Q2 2021$1,557,000
-24.0%
151,986
+36.6%
0.00%0.0%
Q1 2021$2,048,000
-28.6%
111,268
+32.9%
0.00%0.0%
Q4 2020$2,869,00083,7500.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders